BioSpace News Archive

Bone Grafts and Substitutes Market Size to Surpass USD 3.96 Billion by 2030

According to Report, the global bone grafts and substitutes market was estimated at USD 2.80 billion in 2020, and is predicted to surpass around USD 3.96 billion by 2030 with a CAGR of 6.1% from 2022 to 2030.

April 28, 2022
·
5 min read
Generic Drugs Market Size to Reach USD 574.63 Billion by 2027

According to Vision Research Reports, the global generic drugs market was estimated at USD 414.56 billion in 2021 and it is expected to reach USD 574.63 billion by 2027, expanding growth at a CAGR of 5.59% from 2021 to 2027.

April 28, 2022
·
5 min read
BioCapital

MDIC Publishes Framework on External Evidence Methods for Medical Devices

The Medical Device Innovation Consortium, announced the publication of the MDIC External Evidence Methods Framework.

April 28, 2022
·
3 min read
Preclinical CRO Market Size to Surpass US$ 8.9 Billion by 2030

According to Report, the global preclinical CRO market size is expected to surpass around US$ 8.9 billion by 2030 and is anticipated to grow at a CAGR of 8.5% during forecast period 2021 to 2030.

April 28, 2022
·
4 min read
Single-use Bioprocessing Market Size to Garner Around US$ 34 Bn by 2030

According to Precedence Research, the global Single-use Bioprocessing Market size is expected to garner around US$ 34 billion by 2030 from valued at US$ 13 billion in 2020 and growing at a CAGR of 13.3% from 2021 to 2030.

April 28, 2022
·
6 min read
Therma Bright Ships Initial Venowave Order to US Distributor

Despite the challenges of material and component shortages, logistics and shipping delays and lockdowns in various parts of China, the initial order was completed and shipped recently.

April 28, 2022
·
4 min read
Business

Medicago announces the appointment of Toshifumi Tada as President and CEO

Medicago, a biopharmaceutical company headquartered in Quebec City, Canada, announced the appointment of Toshifumi Tada as President and chief executive officer, effective on May 1, 2022.

April 28, 2022
·
2 min read
Policy

Advisory - Apotex recalls Apo-Acyclovir tablets due to a nitrosamine impurity

Apotex Inc. is recalling certain lots of Apo-Acyclovir tablets, in 200 mg and 800 mg strengths, due to the presence of a nitrosamine impurity above the acceptable level.

April 28, 2022
·
3 min read
Business

Sensorion Announces the Publication of Its 2021 Annual Financial Report

Sensorion announces that its annual financial report for the year ending December 31, 2021, is available to the public and filed with the French financial market authority.

April 28, 2022
·
3 min read
Resolutions at BioInvent’s Annual General Meeting 2022

The Annual General Meeting of BioInvent International AB resolved to re-elect the Board members Kristoffer Bissessar, Dharminder Chahal, Thomas Hecht, Leonard Kruimer, Vincent Ossipow and Bernd Seizinger and to implement a long-term incentive program.

April 28, 2022
·
4 min read